[{"notes_id":"1_1079","category":"10","subcategory":"1","title":"Spironolactone","body":"Spironolactone is an <span class=\"concept\" data-cid=\"8590\">aldosterone antagonist<\/span> which acts in the <span class=\"concept\" data-cid=\"6080\">cortical collecting duct<\/span>.<br \/><br \/>Indications<br \/><ul><li><span class=\"concept\" data-cid=\"167\">ascites<\/span>: patients with cirrhosis develop a secondary hyperaldosteronism. Relatively large doses such as 100 or 200mg are often used<\/li><li>hypertension: used in some patients as a NICE 'step 4' treatment<\/li><li>heart failure (see RALES study below)<\/li><li>nephrotic syndrome<\/li><li>Conn's syndrome<\/li><\/ul><br \/>Adverse effects<br \/><ul><li><span class=\"concept\" data-cid=\"8591\">hyperkalaemia<\/span><\/li><li><span class=\"concept\" data-cid=\"8592\">gynaecomastia<\/span>: less common with <span class=\"concept\" data-cid=\"3400\">eplerenone<\/span><\/li><\/ul><br \/>RALES<br \/><ul><li>NYHA III + IV, patients already taking ACE inhibitor<\/li><li>low dose spironolactone reduces all cause mortality<\/li><\/ul>","notes_hash":"b8c9f1e57ef914a8a6f8b9e412075bef","knowledge_graph_node_id_link":0,"links":"","media":"","concepts_for_notes":{"167":{"concept_text":"Ascites - use spironolactone","concept_percentile":"73"},"3400":{"concept_text":"Eplerenone can be used in patients with troublesome gynaecomastia on spironolactone","concept_percentile":"69"},"8590":{"concept_text":"Spironolactone is an aldosterone antagonist ","concept_percentile":"33"},"8591":{"concept_text":"Spironolactone may cause hyperkalaemia","concept_percentile":"47"},"8592":{"concept_text":"Spironolactone may cause gynaecomastia","concept_percentile":"31"}},"category_name":"Renal \/ Urology","subcategory_name":"Renal","comment_count":4},"",[]]